Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE
30-07-2015
Bigul

Code of Conduct of Fair Disclosure

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE about formulation and adoption of Codes under SEBI (Prohibition of Insider Trading) Regulations, 2015.
27-07-2015
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE
22-07-2015
Bigul

Shareholding Pattern For June 30, 2015

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2015.
22-07-2015
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE
17-06-2015
Bigul

Updates

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Company has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Gemifloxacin Mesylate Tablets (320 mg) with 180 days of generic drug exclusivity.
17-06-2015
Bigul

Updates

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Company has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Rivastigmine Capsules in 1.5 mg, 3 mg, 4.5 mg, 6 mg and Felodipine Extended - Release Tablets in 2.5 mg, 5 mg, 10 mg.
12-06-2015
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE
10-06-2015
Bigul

Change in Directorate

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that Shri Sundaram Yuvaraj has vacated his office pursuant to Section 167(b) of the Companies Act 2013 from the Board of Orchid and Shri R. Kannan has been inducted into the Board of the Company as a Non-Executive, Independent director with effect from May 28, 2015.
01-06-2015
Bigul

Financial Results & Results Press Release for March 31, 2015 (Audited)

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE about the Financial Results & a copy of Results Press Release for the period ended March 31, 2015.
29-05-2015
Next Page
Close

Let's Open Free Demat Account